Bod expects to directly sell to the 23 approved prescribers across Australia. Sales therefore can commence immediately following import. In addition to a finished good, Bod will also continue the approval process to import raw material for clinical trials, as well as design and implement clinical trials for specific indications including anti-inflammation, muscle relaxation, anxiety disorders, allergy and asthma, and sleep disorders.
